At our Kollam clinic, every patient gets a personalised trigger map (climate, fabric, soap, food, dust-mite, pet dander) and emollient-application coaching
For patients with cardiovascular or kidney disease, SGLT2 inhibitors or GLP-1 receptor agonists (oral or injectable) may be considered as part of first-line therapy for their cardiorenal benefits
Due to enzymatic degradation and renal clearance (29), endogenous GLP-1 has a short half-life of 1-2 min (30,31)
Who Should (and Shouldn't) Take GLP-1 Medications
If your insurance requires you to use a specific specialty pharmacy, your provider will route the prescription accordingly
found that SGLT2 inhibitors were associated with a decreased incidence of CKD progression among patients with preexisting CKD (RR: 0.77